• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

frederic.hollande@unimelb.edu.au

Credentials


Position
Professor
Department of Clinical Pathology
Education
PhD
Universite Montpellier
PhD
University of Montpellier
Masters (Research)
Universite Montpellier
Bachelors Degree
Universite Montpellier
ORCID

0000-0002-7046-8392

Prof Frederic Hollande

Professor
Department of Clinical Pathology

158 Scholarly works
20 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Carbonic Anhydrase-IX Is a Specific and Sensitive Theragnostic Target for Imaging and Radioimmunotherapy in Metastatic Colorectal Cancer
    DOI: 10.1016/j.gastha.2025.100871
  • 2025

    Journal article

    Exploring and bypassing resistance to targeted therapies in colorectal cancer
    DOI: 10.1016/j.biopha.2025.118741
  • 2025

    Journal article

    Beyond Rodents: Alternative Animal Models in Colorectal Cancer Research
    DOI: 10.3390/ijms262210874
  • 2024

    Journal article

    BRAFV600E-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities
    DOI: 10.1016/j.clcc.2024.04.004
  • 2023

    Research grants (ARC, NHMRC, MRFF)

    Developing Novel Therapeutic Strategies and Predictive Biomarkers in Pancreatic Cancer
  • 2020

    Research Grant

    The Preclinical Validation of Radio-Labelled Girentuximab as a Theranostic Agent in Metastatic Colorectal Cancer
  • 2019

    Research Grant

    Characterising Mechanisms That Underpin Drug Tolerance and Treatment Resistance in Colorectal Cancer Metastases.
Frederic Hollande

RECENT SCHOLARLY WORKS

  • 2024

    Journal article

    BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAFV600E colorectal cancer
    DOI: 10.1038/s41419-024-06478-z
  • 2023

    Journal article

    Type of anesthesia for cancer resection surgery: No differential impact on cancer recurrence in mouse models of breast cancer
    DOI: 10.1371/journal.pone.0293905
  • 2023

    Journal article

    Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping review
    DOI: 10.1007/s00423-023-03133-7
  • 2023

    Journal article

    S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer
    DOI: 10.1038/s41418-023-01126-z
  • 2023

    Journal article

    Correction to: S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer (Cell Death & Differentiation, (2023), 30, 5, (1155-1165), 10.1038/s41418-023-01126-z)
    DOI: 10.1038/s41418-023-01151-y
  • 2023

    Conference Proceedings

    FOLFOX resistance in TP53-mutated Metastatic Colorectal Cancer: mechanism and selective targeting

RECENT PROJECTS

  • 2025

    Research grants (other domestic)

    Netrin-1 Neutralisation as a New Therapeutic Strategy Against Pancreatic Cancer
  • 2026

    Research grants (other domestic)

    Targeting a Novel RNA Processing Pathway for the Treatment of Cancer

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224